The global biomaterials market size was valued at USD 83.9 billion in 2017 and is likely to register a CAGR of 14.7% over the forecast period. Rising occurrence of cardiovascular diseases and orthopedic disorders worldwide, development of implantable instruments and materials, growing number of hip and knee replacement surgeries, advancements in tissue designing, and expanding geriatric population are factors likely to drive the market over the forecast period.
Growing number of clinical diagnostic research studies, increasing R&D investments in molecular biology and precision medicine, and rising private and public partnerships in life science and biotechnology are some of the factors indirectly driving the market.
New entrants in the market are expected to offer stiff competition to established players owing to constant innovation taking place in this field. Nevertheless, leading players will continue to contribute significantly to market growth by focusing on development of new technologies and biomaterial products.
Factors such as stringent regulatory approvals related to commercialization of these materials, inadequate supply of natural tissues, lack of reimbursement policies, and problems pertaining to biocompatibility of biomaterials with living tissues are restraining the market.
Based on the kind of material used, the biomaterials market can be classified into metallic, natural, ceramics, and polymers. Metallic biomaterials include steel, titanium and titanium amalgams, cobalt-chrome combinations, silver, gold, and magnesium, among others.
The polymers segment includes materials made up of silicone elastic, polyethylene, nylon, PLGA, polyester, polyvinyl chloride, and other polymers. This segment emerged dominant in 2017 and is expected to retain its lead throughout the forecast period. Natural biomaterials comprise plant- and animal-based materials such as sodium alginate, cellulose, and natural rubber, tissue-based heart valves, collagen, sutures, hyaluronic acid glycosaminoglycans, and heparin. This segment is expected to register the fastest growth by 2025.
Ceramic biomaterials are made up of alumina, calcium phosphates, bio-glass ceramics and pyrolytic carbon, among others. Ceramics have been successfully used in the repair of hard tissues in orthopedics and dental applications. Most categories of biomaterials are used for restoration of damaged tissues and tissue fixation in surgeries and tissue replacements.
Based on the application of biomaterials in a number of healthcare domains, the market can be segmented into cardiovascular, ophthalmology, dental, orthopedic, wound healing, tissue engineering, and plastic surgery. The cardiovascular segment includes materials such as sensors, stents, guidewires, implantable cardiac defibrillators, pacemakers, and vascular grafts.
The cardiovascular segment is highly lucrative and is estimated to register a CAGR of 15.4% during the forecast period. Segment growth can be attributed to due to increasing cases of heart ailments and complications. The plastic surgery segment is likely to expand at the fastest CAGR of 16.2% during the forecast period, followed by ophthalmology.
Within plastic surgery, biomaterials are used in facial wrinkle treatment, soft tissue fillers, craniofacial surgery, bioengineered skins, peripheral nerve repair, and acellular dermal matrices. This segment is driven by growing trend of cosmetic procedures, increased demand for fat transfer and fat freezing, and increase in demand from the male consumer segment. Obtrusive corrective medical procedures and positive recognition for the same is also driving this segment.
Currently, North America holds the largest revenue share in the market and Asia Pacific is poised to emerge as the fastest growing region by 2025. Factors such as growing industrialization in both developed and developing nations, strong government support, suitable strategic framework, and continuous R&D are expected to drive the market in future.
Asia Pacific, especially economies such as China, India, Japan, and Korea, is a highly lucrative market driven by changing trends. The market is slated to register a CAGR of 15.6% during the forecast period and emerge as an income stash for organizations offering biomaterials.
These materials can be used in place of living tissues wherever compatible and find wide application scope in surgeries, cartilage regeneration, and as a substitute for bones. Thus, leaders in this market are now inclined toward development of more innovative products. In addition, local companies and new entrants are significantly investing in strategic agreements with global firms for business expansions related to research and development in the field.
Some of the major companies operating in this market are DSM; BASF SE; Evonik Industries AG; Berkeley Advanced Biomaterials, Inc.; CAM Bioceramics BV; Carpenter Technology Corporation; Invibio Ltd.; Zimmer Biomet Holdings, Inc.; Covalon Technologies Ltd.; Collagen Matrix, Inc.; Medtronic, Inc.; Purac Biomaterials; Ticona GmbH; Osteotech, Inc.; and Bayer AG.
Base year for estimation
Actual estimates/Historical data
2014 - 2016
2018 - 2025
Revenue in USD Billion and CAGR from 2018 to 2025
North America, Europe, APAC, LATAM, MEA
U.S., Canada, Germany, U.K., Japan, China, Brazil, Mexico, South Africa
Revenue forecast, company share, competitive landscape, growth factors and trends
15% free customization scope (equivalent to 5 analysts working days)
If you need specific information, which is not currently within the scope of the report, we will provide it to you as a part of customization
This report forecasts revenue growth at global, regional, and country levels and provides an analysis on latest industry trends in each of the sub-segments from 2014 to 2025. For this study, Grand View Research has segmented the global biomaterials market report based on product, application, and region:
Product Outlook (Revenue, USD Million, 2014 - 2025)
Application Outlook (Revenue, USD Million, 2014 - 2025)
Implantable Cardiac Defibrillators
Ocular Tissue Replacement
Tissue Regeneration Materials
Bone Grafts & Substitutes
Joint Replacement biomaterials
Bioresorbable Tissue Fixation Products
Fracture Healing Device
Internal Tissue Sealant
Facial Wrinkle Treatment
Soft Tissue Fillers
Peripheral Nerve Repair
Acellular Dermal Matrices
Neural Stem Cell Encapsulation
Hydrogel Scaffold For CNS Repair
Cortical Neural Prosthetics
Regional Outlook (Revenue, USD Million, 2014 - 2025)
Middle East Africa
Avail customized purchase options to meet your exact research needs:
Get your queries resolved from an industry expert.
Design an exclusive study to serve your research needs.
A testimonial for service in the form of BBB "A" Accreditation.
Your personal and confidential information is safe and secure.
"The quality of research they have done for us has been excellent..."